1)Molecular targeted therapies生物靶向治疗
1.Molecular targeted therapies become a study focus in treatment of solid tumors in recent years.生物靶向药物治疗实体瘤成为当前的研究热点,新化学药物的出现使胃癌的化疗策略有了新的发展,此文从分子生物靶向治疗和化疗方面概述抗进展期胃癌转移与复发的新进展。
英文短句/例句
1.Monoclonal Antibody Therapies in Leukemias;单克隆抗体生物靶向治疗白血病的研究进展
2.Studies on Immunodiagnosis and Biological Therapy of Toxoplasmosis;弓形虫病免疫诊断及靶向生物治疗的研究
3.Sunitinib as a molecular targeting agent in renal cell carcinoma分子靶向药物舒尼替尼治疗肾细胞癌
4.How to select targeted agents for advanced kidney cancer?如何选择治疗晚期肾癌的靶向药物?
5.Controversy on Target Therapy of Non-small Cell Lung Cancer非小细胞肺癌靶向药物治疗争论热点
6.Progress and Clinical Evaluation of Tumor-Targeted Therapy Drugs肿瘤靶向治疗药物的进展与临床评价
7.Epidermal growth factor receptor-targeted tumor biotherapies:an advance靶向表皮生长因子受体的肿瘤生物治疗方法研究进展
8.Research advances on targeted treatment of choroidal neovascularization靶向治疗脉络膜新生血管的研究进展
9.Targeting therapy of liposomes should he well matched with the liposome behavior in vivo.脂质体的靶向治疗应用与脂质体的体内生物学行为相一致。
10.Lipiodol Solution of ～(188)Re-labeled TDD Derivative as a Therapeutic Agent for Transhepatic Arterial Embolization in Rabbit Liver Cancer Model: An Initial Study;～（188）Re-TDD衍生物/碘化油对兔VX_2肝癌靶向治疗初步研究
11.Antibody-drug conjugates as targeted cancer therapeutics靶向癌症治疗试剂——抗体-药物偶联物(英文)
12.Study of Antitumor Effects of rmFⅦ-Gen Conjugate by Targeting Tissue Factor;rmFⅦ-Gen复合物靶向TF治疗肿瘤的实验研究
13.Pre-clinical Study on Hepatocellular Carcinoma Therapy by Targeted Gene Drug (ASOR-PLL-hIL12);靶向基因药物（ASOR-PLL-hIL12）治疗肝癌的临床前研究
14.Safety Research of Fe_3O_4 Nanoparticles as Carrier of Lung Magnetic Targeted Drugs Delivery System;肺靶向治疗药物载体Fe_3O_4磁微粒的安全性研究
15.The Synthesis of a Targeted Anti-tumor Agent-sunitinib Malate;肿瘤靶向治疗药物苹果酸舒尼替尼的合成研究
16.A Study of Pazopanib in Chinese Patients with Metastatic Renal Cell Carcinoma;分子靶向药物Pazopanib治疗转移性肾癌的临床研究
17.Research of DNA-Nanoparticle targeted therapy for liver cancer基因纳米复合物对肝癌的靶向性治疗研究
18.Study on the New Photosensitizer ZnPcS4-BSA for Photodynamic Therapy of the CNV in Vivo and in Vitro;新型生物靶向光敏剂酞菁锌介导的光动力疗法治疗CNV体内外实验研究
相关短句/例句
biological target therapy生物靶向性治疗
1.In this article, we used the system theory to analyze the existing problems in the present biological target therapy,and seek the possible approaches to tackle them.肿瘤的生物靶向性治疗是恶性肿瘤治疗的新方法,其试图通过在基因水平上调节与肿瘤发生、发展有密切联系的生命物质来达到治愈肿瘤的目的。
3)targeted therapy against tumor靶向治疗药物
4)target therapy靶向治疗
1.New drug for non-small cell lung cancer target therapy-erlotinib;非小细胞肺癌靶向治疗新药——厄洛替尼
2.Target therapy of gefitinib in advanced adenocarcinoma of the lung;吉非替尼(Iressa)在晚期肺腺癌的靶向治疗疗效观察
3.The study progress on molecular target therapy to aim directly at signal transduction pathway of human epidermal growth factor receptors;针对人表皮生长因子受体信号传导途径的乳腺癌分子靶向治疗新进展
5)targeting therapy靶向治疗
1.Targeting therapy with docetaxel thermosensitive nano-micelles of human gastric cancer xenografts in nude mice;多希紫杉醇温敏纳米胶束对人胃癌裸鼠移植瘤的靶向治疗作用
2.Targeting therapy of paclitaxel thermosensitive nano-micelle for human gastric cancer xenografts in nude mice;紫杉醇温敏纳米胶束对人胃癌裸鼠移植瘤的靶向治疗作用
3.Gene therapy and radionuclides targeting therapyin mammary carcinoma;乳腺癌的基因治疗与核素靶向治疗
6)targeted therapy靶向治疗
1.Development of targeted therapy on gastroeternaral tumor;消化道肿瘤靶向治疗进展
2.Advances in the targeted therapy of cancer:multi-targeted Raf kinase inhibitor;肿瘤靶向治疗新探:多靶点Raf激酶抑制剂
3.The progression of the role of HSP90 in estrogen receptor pathway in breast neoplasms——the rationale of a new idea of targeted therapy on breast carcinoma;乳腺癌ER信号途径中HSP90作用之研究进展——一种乳腺癌新的靶向治疗思路的理论基础
延伸阅读
靶向给药分子式：CAS号：性质：靶制剂选择性地与靶细胞结合产生药理效应的过程。由于不同的给药途径药靶物制剂可以进入不同的位置，而产后不同的靶向性和作用特点。如脂质体制剂，可以静脉、腹腔、肌肉、皮下或淋巴结注射，也可以支气管给药或大脑内、脊椎给药。静脉给药时，脂质体在体内优先被富含网状内皮细胞的组织（肝脾）所摄取，并迅速被单核吞噬细胞吞噬和降解。主要包括脂质体给药系统、受体靶向及磁性药物。脂质体制剂是把药物包裹在双分子脂质膜中，此种磷脂膜与生物膜类似，成为药物的载体，它与细胞膜亲和力强，使癌细胞摄取增多，提高疗效，增加耐受性。受体靶向是利用脂质体的表面有共价键与抗肿瘤细胞表面抗原的单克隆抗体结合，使脂质体在肿瘤细胞内大量集中，提高抗肿瘤细胞的选择性。磁性药物是指药物与高磁性的硫酸铁结合，在给药后，体外使用强大的磁场，使肿瘤部位处于此种强大磁场之下，药物被选择性地集中在肿瘤细胞，提高治疗指数。
